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Abstract:  
 
The incidence and multiplicity of grossly observed and microscopic lesions of the respiratory 
tract of A/J mice exposed nose-only to mainstream smoke (50, 200, or 400 mg total particulate 
matter/m3 from 2R4F cigarettes) was compared to those of filtered air controls. Animals were 
necropsied at the end of exposure (5 mo) or following 4 or 7 mo of recovery. Lungs were 
visually inspected for tumors at all necropsies and examined histopathologically at 9 and 12 mo. 
At 5 mo no tumors were recorded. No significant elevations in tumor incidence or multiplicity 
were recorded although at 9 mo multiplicity was elevated in the mid-exposure group (0.90 versus 
0.55 tumors per animal for controls). At 12 mo, multiplicity was increased over the 9-mo 
necropsy at all exposures except 200 mg/m3; however, there were no dose-related trends in 
multiplicity or incidence. Histopathological alterations included hyperplasia, metaplasia, and 
inflammation of the nose and larynx and proliferative lesions of the lungs. At 9 mo, the 
multiplicity of focal lung lesions was 1.4 per animal in controls but averaged 1.0 among smoke-
exposed groups. There was an inverse relation (p < .059) between smoke concentration and the 
percentage of hyperplastic lesions at 9 mo. At 12 mo the high-exposure group had slightly 
increased multiplicity of 2.3 lesions compared with 1.6 among controls, while the percentage of 
hyperplasic lesions was similar between groups. Nose-only inhalation of mainstream tobacco 
smoke resulted in chronic inflammatory changes of the respiratory tract yet failed to produce 
statistically significant changes in tumor incidence or multiplicity. 
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Article:  
 
The International Agency for Research on Cancer (IARC, 2004) has classified cigarette smoke as 
a known human carcinogen. An appropriately sensitive, reproducible, and relevant animal model 
for smoke-induced lung tumorigenesis has not been clearly identified. Reviews on the use of rats 
and mice (Coggins, 2000) as well as hamsters, dogs, and nonhuman primates (Coggins, 2001) 
report that studies of cigarette smoke exposure fail to demonstrate a robust increase in the 
incidence of respiratory tract tumors. A follow-up review by Coggins (2002) reiterated the lack 
of respiratory-tract tumors in experimental animals. However, Hutt et al. (2005) recently 
reported a modest increase in pulmonary carcinoma in B6C3F1 mice exposed whole body for the 
entire life span. Hecht (2005) provides an up-to-date review of cigarette smoke inhalation studies 
that highlights the positive results of Hutt et al. (2005) and provides brief discussion of results 
with the A/J mouse. 
 
Studies employing the A/J mouse have reportedly shown cigarette smoke-induced tumorigenesis. 
Witschi et al. (1997) exposed male A/J mice to a 89% sidestream/11% mainstream smoke (MS) 
mixture and necropsied animals at the end of the 5-mo exposure or after an additional 4 mo of 
recovery in air. After a recovery period, smoke exposure was associated with increased 
multiplicity of lung tumors. Witschi (2005a) reviewed 18 carcinogenesis studies using the A/J 
mouse exposed to tobacco smoke and reported tobacco smoke exposure was associated with 
increased tumor multiplicity and incidence in 83% and 56% of the studies, respectively. Witschi 
performed an additional review of the A/J mouse as a model system for tobacco smoke 
tumorigenesis in which multiple single-dose exposures studies were pieced together to generate a 
dose-response analysis of tumor multiplicity (Witschi, 2005b). While there is a relationship 
between smoke dose and lung tumor multiplicity, the slope of the curve is shallow (Witschi, 
2005b). Based on the shallowness of the dose-response and the generally low lung tumor 
multiplicity following smoke exposure, Witschi (2005a, 2005b) concluded that cigarette smoke 
is a weak animal carcinogen. However, despite the weak response, studies in multiple 
laboratories (D’Agostini, 2001; Curtin et al., 2004; Stinn et al., 2005) have been able to 
reproduce similar increases in tumor incidence and multiplicity in the A/J mouse. 
 
The objective of this study was to assess histological lesions in A/J mice exposed nose-only to 
mainstream smoke (MS) generated from 2R4F Kentucky reference cigarettes at concentrations 
of 50, 200, or 400 mg total particulate matter (TPM)/m3.A negative control of filtered air (Sham 
control group) with 0 mg TPM/m3 was compared with the MS exposure groups. Also, a 50 ppm 
sulfur dioxide (SO2) group was included as a positive control for the possible effects of chronic 
irritation on proliferative processes in the lung. However, complete histopathology was not 
conducted on this study arm therefore the data is not shown. As part of the evaluation, lungs 
were fixed and evaluated histologically for the presence of additional tumors and preneoplastic, 
proliferative lesions. 
 
Methods 
 
Test Article 
 
The test article was the MS from 2R4F Kentucky reference cigarettes purchased from the 
University of Kentucky, Lexington, KY. All cigarettes were stored at room temperature in a 
secure location in their original cartons until use. All cigarettes were conditioned prior to use by 
storage in an enclosure for at least 48 h at 70 ± 2◦F and 60 ± 3% humidity. 
 
Animals and Animal Maintenance 
Receipt, Housing, Group Assignment, and Environment 
 
Three hundred seventy-five male A/J mice 6 to 8 wk old were purchased from the Jackson 
Laboratory (Bar Harbor, ME). Animals received water and certified rodent diet 5002 (PMI 
Nutrition International, Inc., Brentwood, MO) ad libitum, except during exposure periods. Blood 
was collected from six animals prior to the initiation of exposures and three surviving animals at 
the time of the terminal necropsies and screened for a variety of common respiratory infectious 
agents. All serological findings were negative. 
 
During nonexposure hours the animals were housed in 2-m3 model H-2000 exposure chambers 
(Hazelton Systems, Inc., Aberdeen, MD). The animals were housed individually in suspended 
stainless-steel wire mesh cages equipped with an automatic drinking water supply system and 
food trays. Following quarantine, suitable animals (total 260) were randomly assigned to control 
or treatment groups using a body weight stratification procedure. Three housing chambers were 
used: one for the air control group and two for smoke-exposed groups. Temperature, relative 
humidity (RH), and airflow were monitored continuously; temperature was maintained between 
20 and 24◦C, the relative humidity (RH) between 50 and 70%, and there were 15 ± 3 air 
changes/h. 
 
Experimental Design 
 
Groups of 65 male mice were assigned to 1 of 4 exposure groups and exposed to diluted MS 
generated from 2R4F cigarettes or filtered air (sham control). Cigarette smoke exposures were 
conducted at TPM target concentrations of 50, 200, or 400 mg/m3 (low, mid, and high exposure 
groups, respectively) of diluted MS. Exposures were conducted for 3 h/day, 5 days/wk for 5 mo. 
The experimental design is summarized in Table 1. Briefly, each group of animals was divided 
into five subgroups: interim, terminal, first recovery, second recovery, and surveillance. The 
interim group consisted of 5 animals per exposure group and was necropsied at the end of 1 wk 
of exposures (5 consecutive days). Tissues, bone marrow, and blood were collected for weighing 
or future analysis. Following the interim necropsy, five additional animals were placed in each 
group and assigned to the second recovery group. The terminal group consisted of 15 animals per 
exposure group and was necropsied at the end of a 5-mo exposure period. The first and second 
recovery groups consisted of 20 animals each per exposure group and were maintained following 
exposure termination and necropsied at either 9 mo (first recovery group) or 12 mo (second 
recovery group). Finally, the surveillance animals consisted of five sentinel mice per exposure 
group and through the measurement of carboxyhemoglobin, nicotine, and cotine were used to 
verify and generally quantify at periodic intervals the exposure regimen. During the course of the 
study, tissues were also collected for gene expression studies (data not presented). 
 
Inhalation Exposure Laboratory Conditions 
 
Cigarette smoke exposures were conducted in a laboratory equipped with 64-port nose-only 
inhalation exposure chambers (Lab Products Inc., Seaford, DE) contained in acrylic enclosures. 
During the inhalation exposures the mice were held in nose-only exposure animal holding tubes 
(CH Technologies (USA), Inc., Westwood, NJ). Animal tube loading and unloading and tube 
insertion and removal from the exposure chamber manifold were performed according to 
standard procedures designed to minimize stress to mice. The mice were acclimated to the 
holding tubes for 3 days prior to exposure. Following exposure, the holders were removed from 
the chamber. The mice were removed from the holders and returned to their cages. 
 
 
 
Test Atmosphere Generation 
 
The cigarette smoke test atmospheres were generated using 30-port Condor smoking machines 
(Borgwaldt-KC, Richmond, VA). Each exposure chamber had a dedicated smoking machine. 
Conditioned cigarettes were smoked in basic conformity with ISO Standards 3308 and 4387. The 
smoking machines were supplied with pressure-regulated, filtered, conditioned air. Vacuum 
exhaust for the smoke machines was provided by a dedicated regenerative ring blower and 
exhausted outside the building. The mainstream smoke was diluted in two steps with breathable 
quality air: first a 1:60 dilution immediately at the exit of the smoke pump and with a second 
dilution set to the levels required to attain the target smoke concentration. 
 
In this study, the puffs per cigarette ranged from 9.2 to 9.4 for all cigarettes used in this study 
with a 35 ± 0.5 mm butt length and a puff volume of 35 ml over a two-second puffing period 
taken once each minute. Sham control animals were exposed to filtered air in an AMESA 
(AMESA Electronics, Geneva, Switzerland) air control chamber. 
 
Test Atmosphere Monitoring 
 
During each inhalation exposure period, the TPM concentration for smoke-exposed groups was 
determined at least three times per exposure in each smoke chamber (once from filtered air) 
using a gravimetric filter-collection method. Samples were collected from exposure ports with 
sampling parameters chosen to collect approximately 4 mg TPM per filter. In addition, real-time 
monitors (RAM sensor) were used to monitor aerosol concentration. 
 
CO levels were monitored continuously in the smoke exposure and sham control chambers with 
an infrared gas analyzer (Model ZRH, California Analytical Instruments, Inc., Orange, CA). The 
instrument was calibrated during the test atmosphere development, and the calibration was 
checked prior to exposure with a zero air standard and an appropriate CO standard. 
 
Aerosol particle size distribution was determined monthly in each chamber (excluding sham 
control) using a quartz crystal microbalance (QCM) based 10-stage cascade impactor (California 
Measurements, Inc., Sierra Madre, CA) at a sampling rate of 0.24 L/min. The mass median 
aerodynamic diameter (MMAD) and geometric standard deviation (GSD) were calculated from 
the mass accumulated on each stage of the QCM. 
 
Exposure Biomarkers 
 
During exposure wk 3, 11, 19, and recovery wk 1, 5 mice per group designated as sentinels were 
bled for determination of carboxyhemoglobin (COHb) levels in blood. As soon as possible 
(within minutes) after being removed from the exposure chamber, the animals were anesthetized 
with 70% CO2/30% O2, bled from the retro-orbital sinus using a tube with ethylenediamine 
tetraacetic acid (EDTA), and the level of COHb was determined using an IL-482 CO-oximeter 
(Instrumentation Laboratory, Inc., Lexington, MA). During exposure wk 7, 15 and recovery wk 
4, sentinel mice were bled for nicotine and cotinine blood level determinations by 
radioimmunoassay (Van Vunakis et al., 1987). 
 
Toxicology Endpoints 
 
Body Weights and Clinical Observations 
 
Animals were observed twice daily for mortality or moribundity. Body weights were measured 
on study day 8 and at weekly intervals thereafter, including during the recovery period. 
 
Hematology and Clinical Chemistry 
 
Hematology and clinical chemistry studies were performed on those mice designated for terminal 
necropsy at exposure termination. Blood was obtained from the retro-orbital sinus of 
anesthetized (70% CO2/30% O2) animals in a predesignated order stratifying exposure groups 
over bleed time. Analysis of hematology and clinical chemistry samples was performed as 
detailed in Heck et al. (2002) with the exception that hematological parameters were evaluated 
using the ADVIA 120 hematology system (Bayer Corp., Tarrytown, NY). 
 
Mortem and Postmortem Procedures 
 
Euthanization and Necropsy 
 
At necropsy, mice were euthanized by intraperitoneal injection of an overdose of sodium 
pentobarbital. Moribund animals were euthanized by intraperitoneal injection of an overdose of 
sodium pentobarbital or carbon dioxide asphyxiation. Complete gross postmortem examinations 
were performed on all animals. The surface of the lungs of each animal was examined for visible 
lesions. The weights of the brain, heart, kidneys, liver, lungs, spleen, testes, and thymus were 
recorded. 
 
Tissue Preservation 
 
The following tissues were collected and preserved in 10% neutral buffered formalin: bone 
marrow (femur), brain (medulla/pons, cerebrum, and cerebellum), heart, kidneys, larynx, liver, 
lungs, nose (nasal turbinates), trachea, and gross lesions. In addition, nasal passages were flushed 
with formalin before being immersed in fixative and the lungs were inflated with formalin via 
the trachea. 
 
Histopathological Evaluations 
 
Histopathology evaluations were performed on the following tissues collected at the 5-, 9-, and 
12-mo necropsies: larynx, lungs (with mainstem bronchi), nose (nasal turbinates), trachea, and 
gross lesions. These tissues were embedded in paraffin, processed by routine histological 
methods, stained with hematoxylin and eosin, and evaluated microscopically by a board- 
certified veterinary pathologist. Additional histopathology was performed on the lungs from 
animals at 9- and 12-mo time points and consisted of sections taken every 200 μm and stained 
with hematoxylin and eosin for evaluation. 
 
Respiratory-Tract Tissue Sectioning 
 
The lungs were sectioned according to Dungworth et al. (1976). Laryngeal sections were taken in 
the narrowly delineated base of the epiglottis, overlying glands in the ventral epiglottal area 
(Coggins et al., 1980). If subepithelial glands were absent from the section, the section was 
considered to be in the wrong area for evaluation. A block containing a longitudinal section of 
distal trachea (distal to larynx) was prepared to include the bronchial bifurcation. Using the 
technique of Young (1981) the respiratory epithelium of the nasoturbinate, maxilloturbinate, and 
walls of the nasal cavity were examined. 
 
Statistical Procedures 
 
Clinical observations were tabulated, but not statistically analyzed. All other toxicology data 
were analyzed using Tukey’s HSD procedure. Tukey’s HSD procedure is a pairwise comparison 
procedure, wherein all treatment groups are compared to all other groups, which controls the 
Type I error rate for the family of all pairwise comparisons. While all groups were compared, for 
purposes of this study, the comparisons of interest consisted of each cigarette group with the 
sham control group. Data were analyzed with SYSTAT (Systat Software, Inc., Point Richmond, 
CA, version 10.2). A significance level of α = .05 was used for all comparisons. 
 
Proliferation Data 
 
The ratio was defined as  
 
 
 
Animals with at least one hyperplasia but no adenomas or carcinomas were all given the same 
very large (999) ratio. The value chosen is inconsequential to the analysis (described later), as 
long as it is larger than all other observed ratios. Animals judged not to have any of the three 
histopathologic conditions were omitted from the analysis. The Jonckheere–Terpstra (JT) test 
(Richter & Higgins, 2006) was used to assess the null hypothesis of no difference in Ratio 
distribution across the groups against the alternative hypothesis that the Ratio tends to decrease 
across groups (i.e., as concentration increases). 
 
Incidence of Histological Alterations 
 
Logistic regression was used to assess change in incidence of lesions as a function of group. 
Since sample sizes were small and there often occurred perfect discrimination among groups (all 
0% or 100% incidence rates); exact inference using conditional maximum likelihood estimation 
was used to improve results (Agresti, 1996). Reported are odds ratio estimates and p values for 
testing the hypothesis that the odds ratio is equal to 1 (equal odds). The explanatory variable, 
Group, was treated as an ordinal variable assuming equally spaced categories. Thus, an odds 
ratio is interpreted as the factor by which the odds of a lesion are higher when comparing a 
Group category to the previous category. 
 
The family-wise confidence level for Tables 4 to 6 was 95%, which means that there is 
simultaneous 95% confidence that all intervals in the table contain the true population odds ratio. 
In order to achieve this, individual confidence intervals were computed using a conservative (1 − 
0.05/25)∗100% = 99.8% confidence level for Table 4 and (1 − 0.05/17)∗100% = 99.7% level for 
Tables 5 and 6. Any intervals with a lower bound greater than 1 indicate statistically significant 
evidence of increased incidence of lesions at the family-wise 5% level (equivalently, statistical 
significance can be concluded if the p value is less than .002 for Table 4 or less than .003 for 
Tables 5 and 6). 
 
For example, for the first variable (Hyperplasia, respiratory epithelium) in Table 4, the odds of 
lesion for a given Group are estimated to be 59.8 times the odds for the Group with the next 
lowest concentration. With 99.8% confidence, this factor is at least 3.19. Since this lower bound 
is greater than 1, this result is statistically significant at the 5% (familywise) level. (Equivalently, 
the p value less than .002 also indicates a statistically significant result.) 
 
Note: In some cases, due to the pattern of responses, only a lower bound on the confidence 
interval can be computed, and the upper bound is denoted as “∞” (infinity). 
 
RESULTS 
 
Smoke Exposure 
 
The overall mean TPM concentrations with standard deviations for the target levels set at 50, 
200, and 400 mg TPM/m3 for 2R4F cigarette smoke were 51 ± 3.5,  205 ± 12.8  and 402 ± 19.3 
mg TPM/m3, respectively. The overall mean nicotine concentrations with standard deviations 
were 3.3 ± 0.8, 16.6 ± 2.6, and 31.3 ± 3.5 mg/m3 at each of the test atmosphere target 
concentrations, respectively. The particle size distribution of the smoke generated from each 
cigarette type was well within the respirable range. The mass median aerodynamic diameters 
(MMADs) ranged from 0.30 to 0.33 μm and the geometric standard deviations (GSDs) ranged 
from 1.86 to 1.95. The overall mean CO concentrations with standard deviations were 67 ± 5.0, 
226 ± 14.4, and 453 ± 28.4 ppm at each of the test atmosphere target concentrations, 
respectively. 
 
Mortality and Gross Observations 
 
Forty-one deaths occurred during the study, including 19 in the low exposure group; however, 
due to the lack of correlation with smoke concentration, mortality was generally not considered 
attributable to smoke exposure. Clinical signs generally observed in all exposure groups during 
the exposure period included alopecia, lesions, salivation, and wet inguinal fur, while increased 
clinical observations of tremors and coldness to touch were seen in only smoke exposure groups, 
particularly in the 200 and 400 mg TPM/m3 smoke-exposure groups. The incidences of these 
clinical signs were notably diminished or absent during the recovery period. 
 
The mean body weight increased in all groups throughout the course of the study, even though 
the weight of those mice exposed to cigarette smoke was statistically significantly decreased a 
majority of the time during the exposure period (see Figure 1). The body weight for the 50 mg 
TPM/m3 smoke-exposure group was significantly depressed for the second month of the study 
but at no other time. Following 1 wk of exposure, the mean body weight of animals in the 200 
and 400 mg TPM/m3 smoke-exposure groups was significantly depressed. The 200 mg TPM/m3 
group remained depressed throughout exposure; however, by study day 183, approximately 4 wk 
postexposure, mean body weights for animals in this group were similar to those of the filtered 
air (sham) group. In contrast, the 400 TPM/m3 group remained significantly depressed through 
study day 246. All affected mean body weight and mean weight gains were similar to those of 
the sham exposure group by the end of the study. 
 
 
 
Clinical Chemistry 
 
The following hematology and clinical chemistry parameters were found to be statistically 
significantly affected: hematocrit, total platelet count, percent neutrophil, percent lymphocyte, 
percent eosinophil, absolute neutrophil count, absolute lymphocyte count, absolute eosinophil 
count, absolute large unstained cells, and alkaline phosphatase. In the high exposure group, the 
numbers and percentage of neutrophils were significantly increased whereas the numbers of 
lymphocytes, eosinophils, and large unstained cells were all decreased. The mid concentration 
exposure group also had significant decreases in the numbers of lymphocytes. In addition, the 
percentage of neutrophils was increased while the percentage of lymphocytes and eosinophils 
were both decreased. 
 
Blood oximetry data showed no biologically significant effects on total hemoglobin levels in any 
of the comparisons during the course of the study. Carboxyhemoglobin levels were statistically 
significantly increased in all smoke- exposed groups compared to the filtered air (sham) group in 
a concentration-dependent manner during the exposure period (Table 2). Mean serum nicotine 
and serum cotinine levels showed increases in a concentration-dependent manner in all smoke-
exposed groups compared to the filtered air (sham) group during the exposure period (Table 3); 
increases were statistically significant for the mid and high exposure groups. 
 
 
 
Organ Weights 
 
Absolute organ weights affected included: Terminal Necropsy: liver and testes (400 mg 
TPM/m3). Relative organ weights affected included: Terminal Necropsy: brain (400 mg 
TPM/m3), and final body weight (400 mg TPM/m3); First Recovery Necropsy: final body 
weight (400 mg TPM/m3). All gross lesions observed at necropsy were considered incidental 
and unrelated to smoke exposure. 
 
General Histopathology 
 
Normal epithelium of the nasal passages was one to two cell layers thick, the ventral epiglottal 
floor was two to three cell layers thick, and the trachea possessed a single cell layer. Hyperplasia 
of the epithelium was a prominent finding throughout the respiratory tract, and severity was 
determined by the degree to which the nucleated cell layer was thickened. Within the nasal 
passages, minimal hyperplasia was characterized by loss of the eosinophilic nuclear-free layer at 
the mucosal surface. Increasing severity was scored based upon additional thickness of the 
nucleated cell layer. In addition, cilia that were present in the less severe cases of hyperplasia 
were absent in more severe instances. Metaplasia was diagnosed by the presence of cells with 
polarity altered such that they were oriented horizontal to the basal membrane. In severe 
metaplastic alterations, keratinization was noted. Submucosal inflammation was diagnosed in 
nasal passages and larynx when the submucosa was slightly thickened and diffusely infiltrated 
with neutrophils and mononuclear inflammatory cells. 
 
Histopathological alterations are detailed in Tables 4 through 6. At the terminal necropsy, 
hyperplasia of the respiratory epithelium was a prominent feature noted in the nasal passages, 
larynx and trachea. In general, severity of hyperplasia decreased from the anterior to posterior 
nasal regions, was highest in the larynx and lowest in the trachea. At the lowest smoke exposure 
(50 mg TPM/m3), hyperplasia of the epithelium of the nose and the larynx were noted. In 
addition to changes observed at the low smoke concentration, exposure to 200 mg TPM/m3 
produced severe hyperplasia and metaplastic alterations in nasal level 1. In addition, 200 mg 
TPM/m3 produced lumen exudate within the nasal passages with nasopharyngeal duct epithelia 
hyperplasia, keratinization and chronic inflammation of the larynx, epithelial hyperplasia of the 
trachea, and infiltration and focal accumulation of pigmented macrophages in the lung. At the 
high smoke level (400 mg TPM/m3) there was also subacute submucosal inflammation and 
epithelial atrophy of the nasal passages. 
 
Significant repair was noted in the histopathological lesions observed from the first recovery 
necropsy (detailed in Table 5), but residual lesions were present. By the first recovery necropsy, 
no metaplastic changes of the nasal epithelium were noted and keratinization of the 
larynx/epiglottis was no longer observed. The severity of hyperplasia was greatly reduced; for 
example severity of hyperplasia in nose level 1 had dropped from 3.9 to 0.8. However, 
respiratory epithelium hyperplasia in nose and epithelial cell hyperplasia/metaplasia in larynx 
with associated chronic inflammation were still present in animals recovering from exposure to 
cigarette smoke at 50, 200, or 400 mg TPM/m3. Olfactory epithelium atrophy (often associated 
with subacute submucosal inflammation and lumen exudate) in nose and focal pigmented 
macrophage accumulation in lung were still present at the end of the initial recovery period in 
animals exposed to cigarette smoke at 200 or 400 mg TPM/m3. Further recovery was noted in 
the histopathology lesions observed from the second recovery necropsy (detailed in Table 6), but 
residual lesions (atrophy of olfactory epithelium that often included sub-acute submucosal 
inflammation and lumen exudate in nose and focal pigmented macrophage accumulation in lung) 
were still present at 200 or 400 mg TPM/m3. Only atrophy of the olfactory epithelium and focal 
pigmented macrophages in the lungs remained significantly altered within animals from the 400 
mg TPM/m3exposure group. 
 
 
 
 
 
 
 
Lung Tumorigenesis 
 
The incidence and multiplicity of lesions on the surface of the lung are summarized in Table 7. 
At the 9-mo recovery necropsy, exposure to cigarette smoke at 200 mg TPM/m3  produced in- 
creased multiplicity of masses observed on the surface of the lungs, however this elevation was 
not statistically significant ( p = .065). In Table 8, the lesions on the surface of the lungs of 
animals that underwent histological examination are reported. In all groups, the animals that 
were randomly assigned to the histology group had lower incidence and multiplicity of lung 
lesions. 
 
Histological examination of the lungs, revealed focal proliferative lesions not detected by visual 
inspection at the time of necropsy (Table 9). These lesions included focal hyperplasia, adenoma 
and adenocarcinoma; lesions are depicted in Figure 2A–D. 
 
In the current study, smoke exposure was associated with in 
creased progression of focal hyperplasia to adenoma at 9 mo (Table 10) such that the 
predominant lesion in air-exposed animals was focal hyperplasia and with increasing 
concentrations of smoke exposure there is a trend toward increasing tumor prevalence. However, 
this trend was analyzed for statistical significance using the Jonckheere–Terpstra test and 
analysis ( p value is .0592) indicated moderate but not statistically convincing evidence that the 
ratio of hyperplasias to adenomas and carcinomas tends to decrease as smoke concentration 
increases. The 12-mo data were also analyzed for trend in the conversion of hyperplasia to 
adenoma. The p value is .477, which fails to provide convincing statistical evidence that the ratio 
tends to decrease as group number increases. 
 
DISCUSSION 
 
This study was performed to evaluate the response of A/J mice exposed nose-only to cigarette 
mainstream smoke. The evaluation included thorough histological evaluation of the respiratory 
tract and step-sectioning of the lungs. Nose-only inhalation produced histopathological 
alterations consistent with prior rodent inhalation studies (Coggins, 1998; Heck et al., 2002). 
Alterations included epithelial hyperplasia and inflammation of the nose and larynx as well as 
accumulation of macrophages in the lungs. Examination during recovery demonstrated that a 
number of the alterations decreased in severity but persisted at study termination. Following 4 
mo of recovery, animals continued to display atrophy of the olfactory epithelium, hyperplasia of 
the laryngeal epithelium and accumulations of pigmented macrophages in the lung. This 
persistence underscores the severity of the exposure. 
 
The tumorigenicity of tobacco smoke was difficult to assess in the current study due to the small 
number of animals, high incidence of spontaneous tumors and low tumor multiplicity over 
exposure groups. At the 9-mo necropsy, multiplicity of visually identified lung lesions was 
elevated in the mid-exposure group, although this was not a statistically significant finding. 
Curtin et al. (2004) compared nose-only to whole-body exposure of A/J mice. While whole-body 
exposure produced statistically significant increases in lung tumor incidence and multiplicity, 
nose-only exposure showed only an increasing trend. In addition, most investigations of tobacco 
smoke tumorigenicity in A/J mice have utilized a mixture composed primarily of sidestream 
smoke, and it is conceivable that the response to a sidestream mixture is different than it would 
be to mainstream smoke only. Perhaps the current findings are a reflection of lowered 
responsiveness of nose-only inhalation or mainstream smoke combined with the relatively weak 
carcinogenicity of tobacco smoke in A/J mice (Witschi et al., 2004; Witschi, 2005a). 
 
Most cigarette smoke tumorigenicity studies employing A/J mice have relied on tumor counts on 
the lung surface (Witschi, 2005a; D’Agostini et al., 2001). Curtin et al. (2004), however, 
demonstrated that histological examination of the lung identifies tumors not observed through 
visual inspection of the lungs’ surface. In addition, Curtin et al. demonstrated that microscopic 
examination produced statistically significant elevations in tumor incidence and multiplicity of 
mainstream smoke-exposed A/J mice that were likely to escape detection by gross examination 
only. Similarly, the current study identified numerous additional proliferative lesions using 
microscopic examination, and this emphasizes the need for histological analysis of the lung in 
order to optimize the data yielded. 
 
In the current study, tumors were predominantly adenomas with a small percentage containing 
carcinomatous foci. This is consistent with recent reports that 80% of tumors occurring in 
cigarette smoke exposed A/J mice are adenomas, with additional tumors being adenoma with 
carcinomatous foci or carcinomas (Witschi, 2005a). Similarly, Dixon et al. (1991) performed a 
survey of lung tumors in the A/J mouse and reported that 67% of spontaneous tumors were 
adenomas and the remainder carcinomas. It should be noted that the predominance of adenomas 
represents a possible limitation of murine models (Malkinson, 1998; Hutt et al., 2005). While 
there has been an apparent shift in histologic type of human lung cancer favoring 
adenocarcinoma (Wingo et al., 1999), human lung cancers are more histologically diverse than 
murine and human patients are generally diagnosed with adenocarcinoma rather than adenoma. 
In addition to tumors, histological evaluation of the lung identified a relatively high incidence of 
hyperplastic foci. Witschi et al. (1997) reported that proliferative lesions within the lungs of 
smoke- exposed A/J mice included hyperplasia, adenoma, and adenocarcinoma. While the 
incidence of adenomas and adenocarcinomas was reportedly similar between control and 
exposed groups, no mention is made of the relative prevalence of hyperplastic lesions. In 
addition, Stinn et al. (2005) reported the predominant tumor type in A/J mice is 
bronchioloalveolar adenoma and that approximately 20% of mice had hyperplastic lesions, 
although no breakdown by exposure group was provided. The presence of hyperplastic foci 
generally appears incompletely classified. 
 
Auerbach et al. (1957) reported a histological study of the respiratory epithelium using step 
sections of the tracheobronchial tree of 150 male patients characterized by smoking habits. The 
authors concluded that epithelial-cell hyperplasia, stratification, and metaplasia had the lowest 
incidence in nonsmokers and increased in frequency in proportion to the amount of smoking. As 
the study progressed the authors published additional findings that characterized sections of 
epithelium for hyperplasia, atypical cell morphology, the absence of cilia, and lesions containing 
multiple alterations (Auerbach et al., 1961). Of interest to the current study is the observation 
that smoking appeared to influence epithelial hyperplasia. Even low levels of smoking (<1/2 
package per day consumption) resulted in over 50% of sections with hyperplasia and above 1 
pack per day the percentage of sections with hyperplasia decreased in proportion to the average 
daily consumption of cigarettes. The decreasing proportion of sections from human patients 
containing hyperplasia is similar to findings in the current study. However, in contrast to the 
current study in A/J mice, sections from nonsmoking human patients contained a very small 
incidence of epithelial hyperplasia (2.4%), whereas epithelial hyperplasia was the most frequent 
lesion observed in the air-exposed mice. 
 
 
 
  
 
 
 
 
A potential mechanism of cigarette smoke-induced lung tumorigenesis in A/J mice may involve 
inflammation acting to promote the prevalent spontaneous hyperplastic foci. Promotion has been 
suggested to be a dominant mechanism of lung cancer mortality in human smokers (Hazelton et 
al., 2005), and an association between lung cancer and pulmonary inflammation has been 
suggested (Smith et al., 2006). In addition, cigarette smoke has been shown to be inflammatory 
in murine models (D’hulst et al., 2005; Seagrave et al., 2004). In the current study, cigarette 
smoke exposure was associated with inflammatory changes of the upper respiratory tract and 
changes in peripheral white cell counts indicative of a systemic inflammatory response. 
Inflammation could promote spontaneous hyperplastic lesions in A/J mice. The influence of 
inflammation on tumorigenicity of mice has been demonstrated using strains that differ in their 
sensitivity to tumor promotion by butylated hydroytoluene (BHT). Bauer et al. (2001) 
demonstrated that a sensitive mouse strain displays inflammation following BHT administration 
whereas a tumor- resistant model does not develop an inflammatory response to BHT. 
 
The anti-inflammatory agents aspirin and sulindac (Duperron & Castonguay, 1997) and 
indomethacin (Moody et al., 2001) have been shown to decrease tumorigenicity in the A/J 
mouse. Witschi et al. (2005) demonstrated that the synthetic glucocorticoid dexamethasone 
decreases A/J mouse lung tumor multiplicities. Dexamethasone decreased tumors in smoke-
exposed animals by 35%, and while this was not statistically significant, significant decreases 
occurred in tumor multiplicity of air-exposed mice. Similarly, Estensen et al. (2004) report that 
the synthetic glucocorticoid, budesonide, delays hyperplasia and adenoma formation following 
benzo[a]pyrene (BaP) exposure. 
 
 
 
 
 
Studying the mechanism of tobacco smoke-associated lung tumorigenesis, Stinn et al. (2005) 
demonstrated that smoke exposure was associated with significant elevations in corticosterone. 
Corticosterone is a glucocorticoid and exerts an anti-inflammatory effect. Further evidence for 
the importance of inflammation, and specifically glucocorticoids, in lung tumorienesis was 
provided by Pashko and Schwartz (1996), who reported that adrenalectomized mice develop 
greater numbers of tumors. 
 
The current study demonstrates persistent histological evidence of inflammation within the 
respiratory tract of exposed animals. However, inconsistent with the present results, Stinn et al. 
(2005) report that corticosterone levels rapidly return to control levels during the postexposure 
period. Therefore, with the anti-inflammatory influence of elevated corticosterone dissipating 
with exposure termination, a residual inflammatory stimulus may predominate in the 
postexposure period. A recovery period has been shown to be critical for the development of 
tumors in cigarette smoke-exposed A/J mice (Witschi et al., 1997; D’Agostini et al., 2001), 
whereas 9 mo of continuous cigarette smoke exposure has failed to produce increases in lung 
tumor incidence or multiplicity (Witschi, 2000; D’Agostini et al., 2001). Similarly, Finch et al. 
(1996), using a shortened recovery period, reported an inhibition of tumor formation in smoke-
exposed A/J mice. Interestingly, administration of dexamethasone and myoinositol in the diet of 
smoke-exposed A/J mice after exposure termination prevented the development of tumors seen 
in animals maintained on a control diet following exposure (Witschi et al., 2000). 
 
Our study is the first to report a thorough histopathological examination of the respiratory tract 
from smoke-exposed A/J mice. Results demonstrate a chronic inflammatory response that is not 
resolved after 7 mo of recovery. In addition, there was some indication that smoke exposure 
might influence the progression of hyperplastic lesions. However, greater numbers of animals 
need to be evaluated in order to properly determine the influence of smoke exposure on the 
progression of spontaneous hyperplastic lesions. Regardless, results further demonstrate the need 
for histological examination of the respiratory tract for accurate assessment of lung 
tumorigenicity in A/J mice. 
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